Design Therapeutics Inc (DSGN) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Design Therapeutics Inc   (NASDAQ: DSGN)


Design Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Design Therapeutics Inc's ROI in the second quarter of 2026?
Design Therapeutics Inc recorded a cumulative net loss of $-71 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -33.8%.

Within the Healthcare sector 388 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2026 quarter, so far to 3529, from total ROI ranking in the first quarter of 2026 at 4130.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -10.98 % -14.35 % -17 % -16.98 % -14.62 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 204 220 213 201 214
Return On Investment (TTM) -33.8 % -32.88 % -32.57 % -30.39 % -26.98 %
DSGN's Overall Ranking # 3529 # 4130 # 3623 # 3575 # 3522
Seq. Investment Change TTM -1.21 % -1.05 % -3.43 % -5.69 % -4.95 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -71 -70 -70 -67 -63

DSGN Company Profile >> Back to DSGN Roi Comparisons >> See Annual DSGN Return On Investment



Return On Investment DSGN's Ranking
Within: No.
Industry # 154
Sector # 389
Overall # 3529

Return On Investment Statistics
High Average Low
-5.4 %
-20.87 %
-33.8 %
(Mar 31 2021)   (Jun 30 2026)







Financial Statements
Design Therapeutics Inc's II. Quarter Investments $ 204 Millions DSGN's Balance sheet
Design Therapeutics Inc's II. Quarter Income $ -20 Millions Quarterly DSGN's Income Statement
DSGN's Income by Division See DSGN's Income by Division


DSGN Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 213 244 280 330 385
Y / Y Investment Growth -12.51 % -13 % -15.24 % -14.25 % -
Net Income in Millions -70 -50 -67 -63 -36
Y / Y Net Income Growth - - - - -
Annual Return On Investment -32.74 % -20.35 % -23.88 % -19.16 % -9.22 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
DSGN's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for DSGN's Competitors
Subscribers only: Roi for Design Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for DSGN's Customers

Other Ratios
DSGN's Roa DSGN's Inventory Turnover Ratio DSGN's Growth Rates DSGN's Dividend Statistics
DSGN's Profitability Ratios DSGN's Asset Turnover Ratio DSGN's Dividend Growth
DSGN's Roe DSGN's Valuation Ratios DSGN's Financial Strength Ratios DSGN's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-12T18:25:55+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.